首页 > 最新文献

Infection and Chemotherapy最新文献

英文 中文
Unveiling the Outcomes of Mpox in Pregnancy: A Systematic Review and Single-Arm Meta-Analysis. 揭示妊娠期m痘的结局:一项系统回顾和单组荟萃分析。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-03-01 DOI: 10.3947/ic.2024.0120
I Gde Sastra Winata, Leonardo Leonardo, Rosalia Sylfiasari, Angeline Ekafentie, Surya Sinaga Immanuel, Fenyta Christyani

Background: The global resurgence of mpox, formerly monkeypox, poses an emerging threat to pregnant women due to immunological changes and potential vertical transmission, yet its impact on pregnancy remains underexplored. This study aims to pioneer a comprehensive assessment of pregnancy outcomes and the risks of vertical transmission associated with mpox infection during pregnancy.

Materials and methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched three databases up to September 2024 for studies on pregnant women with mpox confirmed by quantitative polymerase chain reaction. Primary outcomes were composite adverse pregnancy outcomes: miscarriage or fetal death, congenital anomalies, and chorioamnionitis; the secondary outcome was vertical transmission. Study quality was assessed using Joanna Briggs Institute tools. Statistical analysis employed R software using a one-proportion model with Freeman-Tukey transformation and random-effects meta-analysis (restricted maximum-likelihood estimator, Knapp-Hartung adjustment), presenting estimated proportions with 95% confidence intervals (CIs).

Results: Six studies (three case series, three case reports) comprising 11 singleton pregnancies were included. Diagnoses occurred in the first (27.3%), second (45.4%), and third trimesters (27.3%). Among the five genotypically identified Mpox cases, 20.0% were classified Clade I and 80.0% as Clade II. Meta-analysis indicated that an estimated 63% (95% CI, 43-83%) of pregnancies experienced composite adverse pregnancy outcomes. Specifically, miscarriage or fetal death occurred in 62% (95% CI, 21-102%), congenital anomalies in 50% (95% CI, 21-80%), and chorioamnionitis in 78% (95% CI, 44-96%). Vertical transmission was observed in 79% (95% CI, 6-151%). Despite small sample sizes leading to wide confidence intervals, high estimated proportions suggest that mpox severely impacts pregnancy outcomes, likely linked to maternal inflammation, placental invasion, and significant fetal risks from vertical transmission.

Conclusion: Mpox infection during pregnancy appears to be associated with high rates of adverse pregnancy outcomes and vertical transmission. Further large-scale studies are warranted to confirm these findings and develop preventive and management strategies mitigating this emerging threat.

背景:由于免疫变化和潜在的垂直传播,全球麻疹(原猴痘)的死灰复燃对孕妇构成了新的威胁,但其对妊娠的影响仍未得到充分探讨。本研究旨在对妊娠结局和妊娠期间与m痘感染相关的垂直传播风险进行全面评估。材料和方法:根据系统评价和荟萃分析指南的首选报告项目,我们检索了三个数据库,截至2024年9月,通过定量聚合酶链反应证实的孕妇m痘研究。主要结局是复合不良妊娠结局:流产或死胎、先天性异常和绒毛膜羊膜炎;次要结果为垂直传播。使用乔安娜布里格斯研究所的工具评估研究质量。统计分析采用R软件,采用一比例模型,采用Freeman-Tukey变换和随机效应荟萃分析(限制性最大似然估计量,Knapp-Hartung调整),估计比例为95%置信区间(ci)。结果:包括11例单胎妊娠的6项研究(3个病例系列,3个病例报告)。诊断发生在妊娠早期(27.3%)、中期(45.4%)和晚期(27.3%)。在5例基因典型鉴定的m痘病例中,20.0%为ⅰ支,80.0%为ⅱ支。荟萃分析显示,估计63% (95% CI, 43-83%)的妊娠经历了复合不良妊娠结局。具体来说,流产或胎儿死亡发生率为62% (95% CI, 21-102%),先天性异常发生率为50% (95% CI, 21-80%),绒毛膜羊膜炎发生率为78% (95% CI, 44-96%)。垂直传播率为79% (95% CI, 6-151%)。尽管样本量小导致置信区间宽,但高估计比例表明m痘严重影响妊娠结局,可能与母体炎症、胎盘侵入和垂直传播对胎儿的重大风险有关。结论:妊娠期m痘感染与妊娠不良结局和垂直传播的高发率有关。有必要进一步进行大规模研究,以证实这些发现,并制定预防和管理战略,减轻这一新出现的威胁。
{"title":"Unveiling the Outcomes of Mpox in Pregnancy: A Systematic Review and Single-Arm Meta-Analysis.","authors":"I Gde Sastra Winata, Leonardo Leonardo, Rosalia Sylfiasari, Angeline Ekafentie, Surya Sinaga Immanuel, Fenyta Christyani","doi":"10.3947/ic.2024.0120","DOIUrl":"10.3947/ic.2024.0120","url":null,"abstract":"<p><strong>Background: </strong>The global resurgence of mpox, formerly monkeypox, poses an emerging threat to pregnant women due to immunological changes and potential vertical transmission, yet its impact on pregnancy remains underexplored. This study aims to pioneer a comprehensive assessment of pregnancy outcomes and the risks of vertical transmission associated with mpox infection during pregnancy.</p><p><strong>Materials and methods: </strong>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched three databases up to September 2024 for studies on pregnant women with mpox confirmed by quantitative polymerase chain reaction. Primary outcomes were composite adverse pregnancy outcomes: miscarriage or fetal death, congenital anomalies, and chorioamnionitis; the secondary outcome was vertical transmission. Study quality was assessed using Joanna Briggs Institute tools. Statistical analysis employed R software using a one-proportion model with Freeman-Tukey transformation and random-effects meta-analysis (restricted maximum-likelihood estimator, Knapp-Hartung adjustment), presenting estimated proportions with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Six studies (three case series, three case reports) comprising 11 singleton pregnancies were included. Diagnoses occurred in the first (27.3%), second (45.4%), and third trimesters (27.3%). Among the five genotypically identified Mpox cases, 20.0% were classified Clade I and 80.0% as Clade II. Meta-analysis indicated that an estimated 63% (95% CI, 43-83%) of pregnancies experienced composite adverse pregnancy outcomes. Specifically, miscarriage or fetal death occurred in 62% (95% CI, 21-102%), congenital anomalies in 50% (95% CI, 21-80%), and chorioamnionitis in 78% (95% CI, 44-96%). Vertical transmission was observed in 79% (95% CI, 6-151%). Despite small sample sizes leading to wide confidence intervals, high estimated proportions suggest that mpox severely impacts pregnancy outcomes, likely linked to maternal inflammation, placental invasion, and significant fetal risks from vertical transmission.</p><p><strong>Conclusion: </strong>Mpox infection during pregnancy appears to be associated with high rates of adverse pregnancy outcomes and vertical transmission. Further large-scale studies are warranted to confirm these findings and develop preventive and management strategies mitigating this emerging threat.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"119-130"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food, Water, Air, and Mind must Become Cleaner. 食物、水、空气和心灵必须变得更清洁。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-03-01 DOI: 10.3947/ic.2024.0136
Josef Finsterer, Carla Alexandra Scorza, Fulvio Alexandre Scorza, Ana Claudia Fiorini
{"title":"Food, Water, Air, and Mind must Become Cleaner.","authors":"Josef Finsterer, Carla Alexandra Scorza, Fulvio Alexandre Scorza, Ana Claudia Fiorini","doi":"10.3947/ic.2024.0136","DOIUrl":"10.3947/ic.2024.0136","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"181-182"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in Escherichia coli Isolates of Clinical Origin. 临床来源大肠埃希菌对碳青霉烯类和氟喹诺酮类药物耐药性的基因决定因素。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-03-01 DOI: 10.3947/ic.2024.0108
Simbiat Tolani Lawal, Fadilulahi Ayokunle Usman, Zainab Adepeju Adams, Omoladun Safurat Ogunbayo, Chioma Margaret Ekwedigwe, Rukayat Olajumoke Jimoh, Fortunate Opeyemi Oladeru, Oyindamola Osho, Utibeima Udo Essiet, Abraham Ajayi, Stella Smith

Background: Antimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once treatable with antibiotics. In this study, we assessed the susceptibility of Escherichia coli strains isolated from clinical samples to carbapenems and fluoroquinolones and screened for genetic determinants mediating resistance.

Materials and methods: This retrospective study included 46 E. coli isolates retrieved from the stock culture collection at the Molecular Biology and Biotechnology Department of the Nigerian Institute of Medical Research. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method, and molecular techniques were employed to detect genetic determinants of antimicrobial resistance.

Results: The E. coli isolates exhibited high resistance to fluoroquinolones, with 72% resistant to ciprofloxacin and 52% to levofloxacin. Resistance to carbapenems was relatively low, with 4% resistant to imipenem and 11% to meropenem. The prevalence of the genetic determinants gyrA, gyrB, and parC, which mediate fluoroquinolone resistance, was 26%, 24%, and 15%, respectively. blaOXA-48 and blaNDM, which mediate carbapenem resistance, were detected in only two isolates. Some isolates harbored plasmids ranging from 5 kb to 16 kb; however, no plasmid-mediated genetic determinants conferring fluoroquinolone resistance were identified.

Conclusion: This study revealed a high level of resistance to fluoroquinolones, emphasizing the need for judicious use of antibiotics, particularly those with low resistance rates. Continuous surveillance is essential to monitor emerging trends in resistance among bacterial pathogens.

背景:抗菌素耐药性已成为一项全球公共卫生挑战,导致曾经可用抗生素治疗的感染的死亡率更高。在这项研究中,我们评估了从临床样本中分离的大肠杆菌菌株对碳青霉烯类和氟喹诺酮类药物的敏感性,并筛选了介导耐药性的遗传决定因素。材料和方法:本回顾性研究包括从尼日利亚医学研究所分子生物学和生物技术部的家畜培养标本中提取的46株大肠杆菌分离株。采用Kirby-Bauer圆盘扩散法进行药敏试验,采用分子技术检测耐药遗传决定因素。结果:分离的大肠杆菌对氟喹诺酮类药物耐药,对环丙沙星耐药72%,对左氧氟沙星耐药52%。对碳青霉烯类的耐药率相对较低,对亚胺培南的耐药率为4%,对美罗培南的耐药率为11%。介导氟喹诺酮类药物耐药性的遗传决定因子gyrA、gyrB和parC的患病率分别为26%、24%和15%。介导碳青霉烯耐药的blaOXA-48和blaNDM仅在两株菌株中检测到。一些分离株含有5 - 16 kb的质粒;然而,没有质粒介导的遗传决定因素确定氟喹诺酮类药物耐药性。结论:本研究揭示了对氟喹诺酮类药物的高耐药性,强调需要明智地使用抗生素,特别是那些耐药率低的抗生素。持续监测对于监测细菌病原体耐药性的新趋势至关重要。
{"title":"Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolates of Clinical Origin.","authors":"Simbiat Tolani Lawal, Fadilulahi Ayokunle Usman, Zainab Adepeju Adams, Omoladun Safurat Ogunbayo, Chioma Margaret Ekwedigwe, Rukayat Olajumoke Jimoh, Fortunate Opeyemi Oladeru, Oyindamola Osho, Utibeima Udo Essiet, Abraham Ajayi, Stella Smith","doi":"10.3947/ic.2024.0108","DOIUrl":"10.3947/ic.2024.0108","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once treatable with antibiotics. In this study, we assessed the susceptibility of <i>Escherichia coli</i> strains isolated from clinical samples to carbapenems and fluoroquinolones and screened for genetic determinants mediating resistance.</p><p><strong>Materials and methods: </strong>This retrospective study included 46 <i>E. coli</i> isolates retrieved from the stock culture collection at the Molecular Biology and Biotechnology Department of the Nigerian Institute of Medical Research. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method, and molecular techniques were employed to detect genetic determinants of antimicrobial resistance.</p><p><strong>Results: </strong>The <i>E. coli</i> isolates exhibited high resistance to fluoroquinolones, with 72% resistant to ciprofloxacin and 52% to levofloxacin. Resistance to carbapenems was relatively low, with 4% resistant to imipenem and 11% to meropenem. The prevalence of the genetic determinants <i>gyrA</i>, <i>gyrB</i>, and <i>parC</i>, which mediate fluoroquinolone resistance, was 26%, 24%, and 15%, respectively. <i>bla</i><sub>OXA-48</sub> and <i>bla</i><sub>NDM</sub>, which mediate carbapenem resistance, were detected in only two isolates. Some isolates harbored plasmids ranging from 5 kb to 16 kb; however, no plasmid-mediated genetic determinants conferring fluoroquinolone resistance were identified.</p><p><strong>Conclusion: </strong>This study revealed a high level of resistance to fluoroquinolones, emphasizing the need for judicious use of antibiotics, particularly those with low resistance rates. Continuous surveillance is essential to monitor emerging trends in resistance among bacterial pathogens.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"102-110"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy. 造血干细胞移植受者在马里巴韦先发制人治疗期间发生巨细胞病毒视网膜炎。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-03-01 Epub Date: 2025-01-22 DOI: 10.3947/ic.2024.0131
Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim

We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.

我们报告一例巨细胞病毒视网膜炎在一个造血干细胞移植受体在缬更昔洛韦先发制人的治疗之后,马里巴韦。UL97突变分析显示C480F取代与高马里巴韦耐药和低更昔洛韦耐药相关。
{"title":"Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy.","authors":"Hyeon Mu Jang, Han-Seung Park, Heungsup Sung, Sung-Han Kim","doi":"10.3947/ic.2024.0131","DOIUrl":"10.3947/ic.2024.0131","url":null,"abstract":"<p><p>We report a case of cytomegalovirus retinitis in a hematopoietic stem cell transplant recipient during valganciclovir pre-emptive therapy followed by maribavir. Analysis of UL97 mutation revealed a C480F substitution associated with high maribavir resistance and low ganciclovir resistance.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"168-171"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding and Addressing Long COVID, the Lingering Shadow of COVID-19. 认识和应对COVID-19长期阴影。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2025-03-01 DOI: 10.3947/ic.2025.0025
Jung Wan Park
{"title":"Understanding and Addressing Long COVID, the Lingering Shadow of COVID-19.","authors":"Jung Wan Park","doi":"10.3947/ic.2025.0025","DOIUrl":"10.3947/ic.2025.0025","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"57 1","pages":"179-180"},"PeriodicalIF":2.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events. 再生障碍性贫血患者感染风险预测模型的开发:复发事件的生存分析
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 Epub Date: 2024-08-30 DOI: 10.3947/ic.2024.0045
Pirun Saelue, Thitichaya Penthinapong

Background: In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.

Materials and methods: Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.

Results: With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.

Conclusion: Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.

背景:在再生障碍性贫血(AA)患者中,感染相关并发症是导致死亡的主要原因。然而,人们对这些患者感染的预测因素了解有限。因此,本研究旨在评估感染的风险因素,并建立一个AA患者发生感染的风险预测模型:2004年1月至2020年12月期间,206名年龄≥15岁的AA患者被纳入本研究。采用复发事件方法进行生存分析,以确定与感染相关的预测因素,包括安德森和吉尔模型、普伦蒂斯、威廉姆斯和彼得森(PWP)总时间模型、PWP间隙时间模型、边际模型和虚弱模型。使用后向逐步回归法确定最佳模型,并使用500次重复取样的Bootstrapping法进行内部验证:中位随访时间为 2.95 年,AA 患者的感染发生率为每 100 人年 32.8 例。PWP总时间模型显示,肝硬化合并症、淋巴细胞≥80%和既往感染增加了感染风险,而骨髓细胞率≥20%则提供了保护。骨髓细胞率、淋巴细胞百分比、既往感染、肝硬化和血细胞比容(BLICH)模型用于预测感染风险。内部验证显示该模型校准良好:肝硬化、淋巴细胞≥80%、既往感染和骨髓细胞率
{"title":"Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.","authors":"Pirun Saelue, Thitichaya Penthinapong","doi":"10.3947/ic.2024.0045","DOIUrl":"10.3947/ic.2024.0045","url":null,"abstract":"<p><strong>Background: </strong>In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.</p><p><strong>Materials and methods: </strong>Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.</p><p><strong>Results: </strong>With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.</p><p><strong>Conclusion: </strong>Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"483-491"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Antimicrobial Resistance Trends among Lower Respiratory Tract Pathogens in Crete, Greece, 2017-2022. 2017-2022年希腊克里特岛下呼吸道病原菌患病率及耐药趋势
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0060
Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki
<p><strong>Background: </strong>Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.</p><p><strong>Materials and methods: </strong>Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.</p><p><strong>Results: </strong>A total of 4,008 strains were isolated from 3,427 respiratory samples. <i>Acinetobacter baumannii</i> was the most frequently isolated pathogen (23.1%), followed by <i>Pseudomonas aeruginosa</i> (20.0%), <i>Staphylococcus aureus</i> (10.6%) and <i>Klebsiella pneumoniae</i> (6.8%). The isolation rate of <i>A. baumannii</i> significantly increased during the study period, while there were lower increases in the isolation rates of <i>P. aeruginosa</i>, <i>K. pneumoniae</i> and <i>S. aureus. A. baumannii</i> and <i>P. aeruginosa</i> were more prevalent during summer, <i>K. pneumoniae</i> was more common during autumn, while for <i>S. aureus</i> higher incidence was noted during winter. <i>A. baumannii</i> exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). <i>P. aeruginosa</i> showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant <i>P. aeruginosa</i> were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding <i>K. pneumoniae</i>, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant <i>K. pneumoniae</i> isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for <i>Klebsiella pneumoniae</i> carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of <i>S. aureus</i>, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy
背景:下呼吸道感染(LRTIs)是人类最常见的感染,具有显著的发病率和死亡率。由于抗生素耐药性的增加,下呼吸道感染的管理是复杂的。本研究调查了从下呼吸道感染患者呼吸道样本中分离的细菌的流行情况和耐药性趋势。材料与方法:收集2017年1月至2022年12月在希腊克里特岛伊拉克利安大学医院住院的所有年龄的下呼吸道感染患者的痰液和支气管洗涤液,并由微生物实验室进行分析。采用基质辅助激光解吸电离飞行时间质谱法对分离菌株进行鉴定,并用Vitek 2系统进行药敏试验。结果:从3427份呼吸道样本中共分离出4008株。鲍曼不动杆菌是最常见的病原菌(23.1%),其次是铜绿假单胞菌(20.0%)、金黄色葡萄球菌(10.6%)和肺炎克雷伯菌(6.8%)。研究期间鲍曼假单胞菌的分离率显著上升,铜绿假单胞菌、肺炎克雷伯菌和金黄色葡萄球菌的分离率上升幅度较小。鲍曼不动杆菌和铜绿假单胞菌在夏季较为常见,肺炎克雷伯菌在秋季较为常见,而金黄色葡萄球菌在冬季发病率较高。鲍曼不动杆菌对大多数抗菌药物的耐药率均较高(≥90.0%),对多种药物的耐药率极高(91.0%)。P. aeruginosa对粘菌素的耐药率最低(1.4%)。β-内酰胺类药物对哌拉西林/他唑巴坦、头孢他啶、头孢吡肟、亚胺培南、美罗培南的耐药率分别为26.2%、27%、25.8%、29.2%和29.9%。共有162株(68.1%)耐美罗培尼铜绿假单胞菌同时对头孢他啶和哌拉西林/他唑巴坦耐药。肺炎克雷伯菌对头孢噻肟、头孢曲松、头孢他啶、头孢吡肟等第三代和第四代头孢菌素以及碳青霉烯类、亚胺培南、美罗培南的耐药率为46.2% ~ 53.8%。46.2%的菌株对碳青霉烯类药物耐药。126株耐碳青霉烯肺炎克雷伯菌碳青霉烯酶、新德里金属β-内酰胺酶、维罗纳整合子介导的金属β-内酰胺酶和OXA-48碳青霉烯酶分别阳性83株(65.9%)、30株(23.8%)、9株(7.2%)和4株(4.2%)。金黄色葡萄球菌对甲氧西林耐药的占37.2%。甲氧苄啶/磺胺甲恶唑的耐药率较低(3.3%),庆大霉素(2.8%),利福平(0.9%)。所有分离株均对利奈唑胺、达托霉素、替加环素、替可普宁和万古霉素敏感。结论:定期更新当地微生物流行监测和耐药模式监测对指导经验性下呼吸道感染的治疗至关重要。
{"title":"Prevalence and Antimicrobial Resistance Trends among Lower Respiratory Tract Pathogens in Crete, Greece, 2017-2022.","authors":"Sofia Maraki, Viktoria Eirini Mavromanolaki, Anna Kasimati, Evangelia Iliaki-Giannakoudaki, Dimitra Stafylaki","doi":"10.3947/ic.2024.0060","DOIUrl":"https://doi.org/10.3947/ic.2024.0060","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Lower respiratory tract infections (LRTIs) are the most common infections in humans accounting for significant morbidity and mortality. Management of LRTIs is complicated due to increasing antimicrobial resistance. This study investigated the prevalence and trends of antimicrobial resistance for bacteria isolated from respiratory samples of patients with LRTIs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;Sputum and bronchial washings were collected from patients of all ages hospitalized with LRTIs and were analyzed by the microbiological laboratory in the University Hospital of Heraklion, Crete, Greece, from January 2017 to December 2022. Identification of the bacterial isolates was performed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and antimicrobial susceptibility testing by Vitek 2 system.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 4,008 strains were isolated from 3,427 respiratory samples. &lt;i&gt;Acinetobacter baumannii&lt;/i&gt; was the most frequently isolated pathogen (23.1%), followed by &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; (20.0%), &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (10.6%) and &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; (6.8%). The isolation rate of &lt;i&gt;A. baumannii&lt;/i&gt; significantly increased during the study period, while there were lower increases in the isolation rates of &lt;i&gt;P. aeruginosa&lt;/i&gt;, &lt;i&gt;K. pneumoniae&lt;/i&gt; and &lt;i&gt;S. aureus. A. baumannii&lt;/i&gt; and &lt;i&gt;P. aeruginosa&lt;/i&gt; were more prevalent during summer, &lt;i&gt;K. pneumoniae&lt;/i&gt; was more common during autumn, while for &lt;i&gt;S. aureus&lt;/i&gt; higher incidence was noted during winter. &lt;i&gt;A. baumannii&lt;/i&gt; exhibited high resistance rates (≥90.0%) to most of the antimicrobial agents tested, and extremely high multidrug-resistance (91.0%). &lt;i&gt;P. aeruginosa&lt;/i&gt; showed the lowest rate of resistance for colistin (1.4%). Among β-lactams, resistance rates to piperacillin/tazobactam, ceftazidime, cefepime, imipenem and meropenem were 26.2%, 27%, 25.8%, 29.2% and 29.9%, respectively. A total of 162 (68.1%) meropenem-resistant &lt;i&gt;P. aeruginosa&lt;/i&gt; were simultaneously resistant to ceftazidime and piperacillin/tazobactam. Regarding &lt;i&gt;K. pneumoniae&lt;/i&gt;, high rates of resistance were observed for the third and fourth generation cephalosporins, namely cefotaxime, ceftriaxone, ceftazidime, and cefepime and the carbapenems, imipenem and meropenem ranging from 46.2% to 53.8%. Carbapenem-resistance was detected among 46.2% of the isolates. Among the 126 carbapenem-resistant &lt;i&gt;K. pneumoniae&lt;/i&gt; isolates, 83 (65.9%), 30 (23.8%), 9 (7.2%), and 4 (4.2%) were positive for &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; carbapenemase, New Delhi Metallo-β-lactamase, Verona Integron-Mediated Metallo-β-lactamase and OXA-48 carbapenemase, respectively. Of the total number of &lt;i&gt;S. aureus&lt;/i&gt;, 37.2% were methicillin resistant. Low rates of resistance were detected in trimethoprim/sulfamethoxazole (3.3%), gentamicin (2.8%), and rifampicin (0.9%). All isolates were susceptible to linezolid, daptomycin, tigecy","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"492-501"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns. 人类乳头瘤病毒疫苗接种及相关伦理问题综述。
IF 2.9 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 Epub Date: 2024-08-08 DOI: 10.3947/ic.2024.0070
Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit

Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.

自联邦药品管理局快速批准人类乳头瘤病毒 (HPV) 疫苗以来,该疫苗一直饱受争议。在日本和丹麦,未经证实的不良事件报告导致国家疫苗接种计划暂停,从而阻碍了宫颈癌及其相关死亡率和发病率的防治工作。尽管对疫苗不良反应报告进行了跟踪研究,进行了更多的随机对照试验,世界卫生组织和欧盟委员会也都出具了审查报告,但人们对疫苗仍有很大的疑虑。虽然所有三种版本的 HPV 疫苗都被证明是有效和安全的,但更多的伦理难题也值得考虑。
{"title":"A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns.","authors":"Eric Fu, Ozdemir Erdemir, Khalil Pathan, Meaghan Brophy, Aidan Pettit","doi":"10.3947/ic.2024.0070","DOIUrl":"10.3947/ic.2024.0070","url":null,"abstract":"<p><p>Since its Fast-Track approval by the Federal Drug Administration, the human papillomavirus (HPV) vaccine has been marked by controversies. Unconfirmed reports of adverse events in both Japan and Denmark led to suspensions of national vaccination programs, which setback the fight against cervical cancer and associated mortality and morbidity. Despite follow-up studies of vaccine adverse reports, additional randomized control trials, and review reports from both the World Health Organization and the European Commission, there is still a great deal of hesitancy around the vaccine. While all three version of the HPV vaccine have been shown to be efficacious and safe, additional ethical dilemmas deserve to be considered as well.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"432-439"},"PeriodicalIF":2.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated? 如何诊断和治疗慢性COVID(长冠综合征)?
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0115
Josef Finsterer
{"title":"How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated?","authors":"Josef Finsterer","doi":"10.3947/ic.2024.0115","DOIUrl":"https://doi.org/10.3947/ic.2024.0115","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"559-560"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Antimicrobial Susceptibility of Wound Pathogens in a Tertiary Care Hospital in Kashmir: A Cross-sectional Study. 克什米尔一家三级护理医院伤口病原菌的患病率和抗菌药物敏感性:一项横断面研究。
IF 2.8 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3947/ic.2024.0083
Tabeen Mansoor, Dekyong Angmo, Nahid Nehvi

Background: Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.

Materials and methods: A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.

Results: Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with Escherichia coli being the most prevalent at 27.9%. Among Gram-positive cocci, Staphylococcus aureus predominated, comprising 25.9% of the isolates. Methicillin-resistant S. aureus exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). E. coli demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).

Conclusion: The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.

背景:伤口感染显著影响全球发病率、死亡率和医疗保健成本。克什米尔山谷独特的地理和气候条件,加上资源限制和抗生素滥用,使有效管理这些感染复杂化。本研究旨在确定克什米尔一家三级护理医院伤口感染的主要细菌病原体,确定其抗生素敏感性概况,并估计多重耐药(MDR)菌株的患病率。材料和方法:一项前瞻性横断面研究于2023年1月至6月在斯利那加政府医学院进行。无菌收集伤口感染脓液样本,并按照标准微生物学方案进行处理。抗生素敏感性测试采用Kirby-Bauer圆盘扩散法,遵循临床和实验室标准协会的指导方针。数据采用IBM SPSS统计软件进行分析。结果:在分析的4378个样本中,1921个样本中观察到细菌生长,占总数的43.9%。其中革兰氏阴性杆菌占73.5%,大肠杆菌最多,占27.9%。在革兰氏阳性球菌中,金黄色葡萄球菌占多数,占25.9%。耐甲氧西林金黄色葡萄球菌对利奈唑胺的敏感性为100%,对红霉素(27.0%)和克林霉素(24.0%)的敏感性低。大肠杆菌对替加环素(97.4%)和阿米卡星(75.0%)的敏感性较高,对亚胺培南(45.0%)和哌拉西林-他唑巴坦(57.8%)的敏感性较低。结论:克什米尔地区伤口感染负担沉重,耐多药耐药患病率高,需要全面的抗菌药物管理和感染控制规划。定期监测、教育和研究对于解决该地区的抗生素耐药性和确保有效的伤口感染管理至关重要。
{"title":"Prevalence and Antimicrobial Susceptibility of Wound Pathogens in a Tertiary Care Hospital in Kashmir: A Cross-sectional Study.","authors":"Tabeen Mansoor, Dekyong Angmo, Nahid Nehvi","doi":"10.3947/ic.2024.0083","DOIUrl":"https://doi.org/10.3947/ic.2024.0083","url":null,"abstract":"<p><strong>Background: </strong>Wound infections significantly impact morbidity, mortality, and healthcare costs globally. The Kashmir Valley's unique geographical and climatic conditions, coupled with resource constraints and antibiotic misuse, complicate managing these infections effectively. This study aimed to identify predominant bacterial pathogens in wound infections at a tertiary care hospital in Kashmir, determine their antibiotic susceptibility profiles, and estimate the prevalence of multidrug-resistant (MDR) strains.</p><p><strong>Materials and methods: </strong>A prospective cross-sectional study was conducted from January to June 2023 at the Government Medical College, Srinagar. Pus samples from wound infections were aseptically collected and processed following standard microbiological protocols. Antibiotic susceptibility testing utilized the Kirby-Bauer disk diffusion method, adhering to Clinical and Laboratory Standards Institute guidelines. Data were analyzed using IBM SPSS statistics.</p><p><strong>Results: </strong>Out of 4,378 samples analyzed, bacterial growth was observed in 1,921 samples, representing 43.9% of the total. Among the bacterial isolates, Gram-negative bacilli accounted for 73.5%, with <i>Escherichia coli</i> being the most prevalent at 27.9%. Among Gram-positive cocci, <i>Staphylococcus aureus</i> predominated, comprising 25.9% of the isolates. Methicillin-resistant <i>S. aureus</i> exhibited 100% susceptibility to linezolid but low susceptibility to erythromycin (27.0%) and clindamycin (24.0%). <i>E. coli</i> demonstrated high susceptibility to tigecycline (97.4%) and amikacin (75.0%), but lower susceptibility to imipenem (45.0%) and piperacillin-tazobactam (57.8%).</p><p><strong>Conclusion: </strong>The substantial wound infection burden and high MDR prevalence in Kashmir necessitate comprehensive antimicrobial stewardship and infection control programs. Regular surveillance, education, and research are crucial to address antibiotic resistance and ensure effective wound infection management in the region.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 4","pages":"502-509"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infection and Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1